Tardive dyskinesia (TD) is a potentially irreversible and disfiguring disorder characterized by involuntary movements of the face, tongue, or extremities.
San Diego, CA (PRWEB) July 30, 2012
The media spotlight is often a double-edged sword. No one knows this better than Marilyn Abicht. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.
According to court documents, on May 29th, 2012, a Minnesota woman, Marilyn Abicht, filed a lawsuit in Minnesota District Court (case no. 0:2012cv01278) alleging that Reglan (metoclopramide) caused her tardive dyskinesia. Reglan (metoclopramide) is a drug used to help with the digestive process and reduce the symptoms of acid reflux and heartburn. It has been in the market since 1996. Plaintiff claims she began taking Reglan in 1998 to treat her pancreatitis and esophageal reflux. From 2002 to 2008, she took a generic version of the drug by Pliva, Inc. and shortly after September 2008 she was diagnosed with tardive dyskinesia.
In 2009, the US FDA issued a black box warning that treatment with metoclopramide (Reglan) can cause tardive dyskinesia, a serious movement disorder that is often irreversible. Tardive dyskinesia (TD) is a potentially irreversible and disfiguring disorder characterized by involuntary movements of the face, tongue, or extremities.
AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of severe adverse events from Reglan, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that alleged threat from Reglan remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”
As the FDA reported in November 2010, the risk of developing tardive dyskinesia increases with the duration of treatment and the total cumulative dose. Treatment with metoclopramide for longer than the recommended 12 weeks should be avoided in all but rare cases where therapeutic benefit is thought to outweigh the risk of developing TD.
AttorneyOne.com has further information on Reglan lawsuits including how to get in contact with legal counsel.
Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2012/7/prweb9701133.htm.